Comparison

RFX5

Item no. 18-272-197732
Manufacturer GENWAY
Amount 0.05 mg
Category
Type Antibody
Applications WB, IP
Specific against other
ECLASS 10.1 32160702
ECLASS 11.0 32160702
UNSPSC 12352203
Alias GWB-94EC6F
Similar products 18-272-197732
Available
Genway ID:
GWB-94EC6F
Isotype:
IgG
Immunogen:
Immunogen was a synthetic peptide which represented a portion of human Regulatory Factor X 5 encoded within exon 5 (LocusLink ID 5993) conjugated to KLH. After multiple immunizations in Freund\' s adjuvant serum was collected. Antibodies were affinity purified using the peptide immobilized on solid support.
Antigen Species:
Human
Specificity:
Reacts with RFX5
Target:
RFX5
Concentration:
1 mg/ml
Purification Note:
Antibodies were affinity purified using thepeptide immobilized on solid support. Antibody concentration was determined by
Extinction coefficient:
absorbance at 280 nmof 1. 4 equals 1. 0 mg of IgG. Storage
Buffer:
Tris-citrate/phosphate pH 7-8 0. 1% sodium azide
Application Note:
For IP: Use at a concentration of 1 - 4 µ l. WB: Use at a dilution of 1:500 - 1:5000. Not tested in other applications. Optimal dilutions/concentrations should be determined by the researcher. RFX5 is the regulatory gene responsible for human MHC class II deficiency. Patients with this disease exhibit a characteristic defect in the binding of a nuclear factor RFX to the X box motif of MHC class II promoters. RFX5 is the 75 kDa subunit of the RFX complex which is absolutely essential and highly specific for regulating MHC class II gene expression and control of the immune response. RFX5 is a protein consisting of 616 amino acids.
Function:
Activates transcription from class II MHC promoters. Recognizes X-boxes. Mediates cooperative binding between RFX and NF-Y. RFX binds the X1 box of MHC-II promoters.
Subunit:
RFX consists of at least three different subunits; RFXAP RFX5 and RFX-B/RFXANK; with each subunit representing a separate complementation group. RFX forms cooperative DNA binding complexes with X2BP and CBF/NF-Y. RFX associates with CIITA to form an active transcriptional complex.
Subcellular Location:
Nucleus.
Tissue Specificity:
Ubiquitous.
Domain:
The N-terminus is required for its association with RFXANK and RFXAP for assembly of the RFX complex and for binding of this complex to its X box target site in the MHC-II promoter. The C-terminus mediates cooperative binding between the RFX complex and NF-Y.
Ptm:
Phosphorylated.
Disease:
Defects in RFX5 are a cause of bare lymphocyte syndrome type 2 (BLS2) [MIM:209920]; also known as hereditary MHC class II deficiency or HLA class II-deficient combined immunodeficiency. BLS2 is a severe combined immunodeficiency disease with early onset. It is characterized by a profound defect in constitutive and interferon-gamma induced MHC II expression absence of cellular and humoral T-cell response to antigen challenge hypogammaglobulinemia and impaired antibody production. The consequence include extreme susceptibility to viral bacterial and fungal infections.
Similarity:
Belongs to the RFX family.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 0.05 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close